ARAMIS — is darolutamide set to become the ‘third musketeer’ of nmCRPC?
Crossref DOI link: https://doi.org/10.1038/s41571-019-0191-7
Published Online: 2019-02-26
Published Print: 2019-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Killock, David
Text and Data Mining valid from 2019-02-26
Article History
First Online: 26 February 2019